Raphael Pharmaceutical OTC Stock Forecast - Relative Strength Index
| RAPH Stock | 1.40 0.00 0.00% |
Raphael OTC Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Raphael Pharmaceutical's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 4th of January 2026 the value of rsi of Raphael Pharmaceutical's share price is below 20 indicating that the otc stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Raphael Pharmaceutical based on different types of headlines from major news networks to social media. Using Raphael Pharmaceutical hype-based prediction, you can estimate the value of Raphael Pharmaceutical from the perspective of Raphael Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
Raphael Pharmaceutical after-hype prediction price | USD 1.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Raphael |
Raphael Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Raphael price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Raphael using various technical indicators. When you analyze Raphael charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Raphael Pharmaceutical Volatility | Backtest Raphael Pharmaceutical | Information Ratio |
Raphael Pharmaceutical Trading Date Momentum
| On January 04 2026 Raphael Pharmaceutical was traded for 1.40 at the closing time. The top price for the day was 1.40 and the lowest listed price was 1.40 . There was no trading activity during the period 0.0. Lack of trading volume on January 4, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
| Compare Raphael Pharmaceutical to competition |
Other Forecasting Options for Raphael Pharmaceutical
For every potential investor in Raphael, whether a beginner or expert, Raphael Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Raphael OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Raphael. Basic forecasting techniques help filter out the noise by identifying Raphael Pharmaceutical's price trends.Raphael Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Raphael Pharmaceutical otc stock to make a market-neutral strategy. Peer analysis of Raphael Pharmaceutical could also be used in its relative valuation, which is a method of valuing Raphael Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Raphael Pharmaceutical Technical and Predictive Analytics
The otc stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Raphael Pharmaceutical's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Raphael Pharmaceutical's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Raphael Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Raphael Pharmaceutical otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Raphael Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Raphael Pharmaceutical otc stock market strength indicators, traders can identify Raphael Pharmaceutical entry and exit signals to maximize returns.
Raphael Pharmaceutical Risk Indicators
The analysis of Raphael Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Raphael Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting raphael otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.98 | |||
| Standard Deviation | 21.47 | |||
| Variance | 460.88 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Other Information on Investing in Raphael OTC Stock
Raphael Pharmaceutical financial ratios help investors to determine whether Raphael OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Raphael with respect to the benefits of owning Raphael Pharmaceutical security.